Expanded services aimed at reducing region’s high STI rates, disparities in sexual health The St. Louis area has some of the highest rates of sexually transmitted infections (STIs) in the country, with the burden falling particularly heavily on Black residents and people with sexual orientations and gender identities that are marginalized.
Category: Clinical
ICTS-funded investigator conducts crucial research to better understand, diagnose, and treat rare genetic disease (Links to an external site)
Rare diseases are just what their name implies – each one affects a limited number of people. But with this rarity comes unique challenges, and among the biggest challenges faced by these patients are the roadblocks they encounter with gathering information about their conditions, being properly diagnosed, and finding the best resources and treatment options […]
Structural Intervention Group Performs first St. Louis Jena Valve Procedure (Links to an external site)
The multidisciplinary Structural Intervention group, including Cardiovascular Division faculty members Drs. Zajarias, Sintek, Lasala, and Quader, along with colleagues in Cardiothoracic Surgery, recently performed the first JenaValve procedure for aortic regurgitation at the Barnes-Jewish Hospital site.
The DOLF Project has Initiated a Clinical Trial of New Treatments for Onchocerciasis in Liberia (Links to an external site)
DOLF researchers announce initiation of a major a new clinical trial of treatments for onchocerciasis in Liberia. The study will compare the safety and efficacy of three new combination treatments with a reference treatment of albendazole plus ivermectin.
New sickle cell treatment center opens at BJC (Links to an external site)
ST. LOUIS – Barnes-Jewish Hospital is introducing the 12th sickle cell treatment center in the country. The center is revolutionizing healthcare for the underrepresented community affected by the disease.
Washington University joins NIH cancer screening clinical trials network (Links to an external site)
New network to evaluate emerging technologies in diverse populations Washington University School of Medicine in St. Louis is joining a new clinical trials network launched by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to investigate emerging technologies for cancer screening, with the goal of reducing cancer-related illnesses and deaths. […]
New cell-based immunotherapy offered for melanoma (Links to an external site)
Siteman Cancer Center, based at Barnes-Jewish Hospital and the School of Medicine, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.
New Clinic Will Help Patients with Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) (Links to an external site)
A new clinic headed by Ying (Maggie) Chen, MD, PhD, Associate Professor of Medicine, Nephrology, focuses on helping patients with a genetic form of renal fibrosis – autosomal dominant tubulointerstitial kidney disease (ADTKD) – which ultimately leads to chronic kidney disease (CKD).